FDA-Approved Human Trial Begins for Stem Cell Therapy
Geron Corporation recently launched a study on the effect of human embryonic stem cells on spinal cord injuries in a human patient, marking the first time scientists have tested the therapy on a person in a government-approved trial. The therapy has been tested in animals, but FDA did not approve its use in humans until July.
- "Geron Begins Human Study on Stem Cell Treatment Aimed at Spinal Cord Injuries" (Troise, AP/Chicago Tribune, 10/11).
- "First Patient Treated in Stem Cell Study" (Stein, Washington Post, 10/11).
- "Embryonic Stem Cells Used on Patient for First Time" (Vergano, USA Today, 10/12).